Industries and academies jointly to exert for stem cell researches.

Published: 2005-10-26 06:57:00

Updated: 2005-10-26 06:57:00

A topic on the stem cell research has been most prevailed in the local drug industries and academies, admitting it as one of the fundamental approaches to treat diseases and a paradigm of the drug industry.

Yuhan recently made a joint research agreement with R&L Bio for the cellular therapy th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK